Yi Jiang
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Retinal Development and Disorders 8
- Cancer-related gene regulation 5
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Guohua Lv (7 shared papers)Xiaoling She (7 shared papers)Ming‐Xiang Zou (7 shared papers)Hongchen Liu (5 shared papers)Ling‐Qing Yuan (5 shared papers)Jing Li (5 shared papers)Rongrong Cui (4 shared papers)Xiaobin Wang (5 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Investigative Ophthalmology & Visual Science (8 papers)Frontiers in Oncology (5 papers)Annals of Oncology (4 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yi Jiang
151 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 135
- Hepatology 186
- Cancer Research 311
- Nephrology 113
- Rheumatology 210
- Pathology and Forensic Medicine 233
Countries citing papers authored by Yi Jiang
This map shows the geographic impact of Yi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Jiang more than expected).
Fields of papers citing papers by Yi Jiang
This network shows the impact of papers produced by Yi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Jiang. The network helps show where Yi Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 193 | |
| 2 | 2021 | 99 | |
| 3 | 2015 | 94 | |
| 4 | 2014 | 85 | |
| 5 | 2005 | 81 | |
| 6 | 2012 | 73 | |
| 7 | 2014 | 59 | |
| 8 | 2011 | 57 | |
| 9 | 2016 | 53 | |
| 10 | 2012 | 51 | |
| 11 | 2013 | 51 | |
| 12 | 2020 | 50 | |
| 13 | 2012 | 49 | |
| 14 | 2006 | 44 | |
| 15 | 2014 | 44 | |
| 16 | 2017 | 42 | |
| 17 | 2013 | 41 | |
| 18 | 2018 | 40 | |
| 19 | 2010 | 40 | |
| 20 | 2019 | 37 |
About Yi Jiang
Yi Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 157 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Retinal Development and Disorders (8 papers), Lung Cancer Treatments and Mutations (6 papers), Bone Tumor Diagnosis and Treatments (6 papers), Parasitic infections in humans and animals (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Hepatology (186 citations), Cancer Research (311 citations), Nephrology (113 citations), Rheumatology (210 citations) and Pathology and Forensic Medicine (233 citations). Yi Jiang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Guohua Lv, Xiaoling She, Ming‐Xiang Zou, Hongchen Liu, Ling‐Qing Yuan, Jing Li, Rongrong Cui, Xiaobin Wang, Nan Hu and Qing Miao. Their work appears in journals such as Journal of Clinical Oncology, Investigative Ophthalmology & Visual Science, Frontiers in Oncology, Annals of Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.